Canalblog
Suivre ce blog Administration + Créer mon blog
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
medical device
23 avril 2015

LifeSciences News

LifeSciences News
Many Medicare patients undergo unnecessary routine preoperative tests before cataract surgery More than half of all Medicare patients who have cataract surgery undergo unnecessary routine preoperative testing, despite strong evidence that these tests...
Publicité
Publicité
23 avril 2015

Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark

Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark
Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark Eyenuk Inc. Eyenuk Inc. Website http://www.eyenuk.com Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced...
23 avril 2015

Ophthalmology Innovation Summit @ASCRS, Is there an OIS effect ?

Ophthalmology Innovation Summit @ASCRS, Is there an OIS effect ?
Adresse du Blog sur itunes: https://itunes.apple.com/us/podcast/ophthalmology-innovation-podcast/id904406267?mt=2%E2%80%8B Link, Corley, Chapin discuss funding innovation and private pay opportunities Craig Simak Managing Director at Healthegy and Producer...
3 avril 2015

TEARLAB DEVICE

TEARLAB DEVICE
Link: http://www.tearlab.com Product Information What is TearLab? Manage Your Dry Eye Patients with Confidence The TearLab Osmolarity System is the first objective and quantitative test for diagnosing and managing Dry Eye patients. Fast and accurate results...
1 avril 2015

The TearScience solution for Meibomian Gland Dysfunction

 The TearScience solution for Meibomian Gland Dysfunction
LINK: http://tearscience.com/en/ Give MGD a Second Glance Meibomian Gland Dysfunction is treatable. The TearScience® Solution for MGD allows eye care professionals to safely and effectively identify, diagnose, and treat MGD in four easy steps. With 86%...
Publicité
Publicité
8 février 2015

TearScience® Achieves Korean HIRA Approval

TearScience® Achieves Korean HIRA Approval TearScience’s LipiFlow® Receives HIRA Patient Payment Approval, Paving the Way to Commercial Launch in Korea MORRISVILLE, N.C.,—May 19, 2014—TearScience®, Inc., a privately held medical device company, today...
Publicité
Publicité
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Newsletter
Visiteurs
Depuis la création 33 341
Publicité